Genetics Institute, Inc. was a biotechnology research and development company founded by Thomas Maniatis and Mark Ptashne, two Harvard molecular biologists, in 1980 in Massachusetts.
MIT's Whitehead Institute was one of the seminal non-profit research centers in this field locally, among many others.
's Products (or potential candidates for products) included forms of M-CSF, interleukin-3, interleukin-11 (Neumega), bone morphogenetic protein 2,recombinant human Factor IX, and recombinant human Factor VIII (Recombinate); as well as tissue plasminogen activator and erythropoetin that both involved costly, complex lawsuits over patent infringement with competitors.
created a program to share "a library of several thousand genes and their related proteins that could be scanned for potential new drugs.
technology that allowed it to identify proteins secreted by cells and therefore more likely to be therapeutic in the body.